Allosteric modulators of steroid hormone receptors: Structural dynamics and gene regulation

Endocrine Reviews

Volumn 33, Issue 2, 2012, Pages 271-299

  Kumar, Raj ^a   McEwan, Iain J ^b  

^a Janet Weis Children s Hospital   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; CHOLESTEROL; COMPLEMENTARY DNA; ECDYSONE RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR BETA; ESTROGEN RELATED RECEPTOR GAMMA; GLUCOCORTICOID RECEPTOR; LIGAND; MINERALOCORTICOID RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE RECEPTOR; RECEPTOR PROTEIN; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; RNA POLYMERASE II; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO A1; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D RECEPTOR;

ADRENAL GLAND; ALLOSTERISM; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL MATURATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DIMERIZATION; DNA RESPONSIVE ELEMENT; GENE CONTROL; HOMEOSTASIS; HORMONE PROTEIN COMPLEX; HORMONE RESPONSIVE ELEMENT; HUMAN; HYDROPHOBICITY; LIGAND BINDING; LIPOPHILICITY; METABOLIC REGULATION; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; REPRODUCTION; REVIEW; STEROIDOGENESIS; TRANSCRIPTION INITIATION;

GENE EXPRESSION REGULATION; HUMANS; LIGANDS; MODELS, MOLECULAR; PROTEIN CONFORMATION; RECEPTORS, STEROID; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS;

EID: 84862635896     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2011-1033     Document Type: Review

References (250)

1. Gronemeyer H, Gustafsson JA, Laudet V 2004 Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3:950-964
2. Yang X, Lamia KA, Evans RM 2007 Nuclear receptors, metabolism, and the circadian clock. Cold Spring Harb Symp Quant Biol 72:387-394
3. Beck IM, Vanden BergheW, Vermeulen L, Yamamoto KR, Haegeman G, De Bosscher K 2009 Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev 30: 830-882
4. McEwan IJ 2009 Nuclear receptors: one big family. Methods Mol Biol 505:3-18
5. Stanisiæ V, Lonard DM, O'Malley BW 2010 Modulation of steroid hormone receptor activity. Prog Brain Res 181: 153-176
6. Briet M, Schiffrin EL 2010 Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol 6:261-273
7. Lanz RB, Bulynko Y, Malovannaya A, Labhart P, Wang L, Li W, Qin J, Harper M, O'Malley BW 2010 Global characterization of transcriptional impact of the SRC-3 coregulator. Mol Endocrinol 24:859-872
8. Vicent GP, Nacht AS, Zaurín R, Ballaré C, Clausell J, Beato M 2010 Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin. Mol Endocrinol 24:2088-2098
9. Zhao C, Dahlman-Wright K, Gustafsson JÅ 2010 Estrogen signaling via estrogen receptor β. J Biol Chem 285:39575-39579
10. Oakley RH, Cidlowski JA 2011 Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem 286:3177-3184
11. Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, Metzger D, Li M, Chambon P 2011 Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145:224-241
12. Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, JavittNB, Korach KS, ShaulPW, Mangelsdorf DJ 2007 27-Hydroxycholesterol is an endogenousSERMthat inhibits the cardiovascular effects of estrogen. Nat Med 13:1185-1192
13. Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E 2008 A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29:133-154
14. Bhasin S, Jasuja R 2009 Selective androgen receptor modulators as function promoting therapies. Curr Opin Clin Nutr Metab Care 12:232-240
15. Funder JW, Reincke M 2010 Aldosterone: a cardiovascular risk factor? Biochim Biophys Acta 1802:1188-1192
16. Konduri SD, Medisetty R, Liu W, Kaipparettu BA, Srivastava P, Brauch H, Fritz P, Swetzig WM, Gardner AE, Khan SA, Das GM 2010 Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. Proc Natl Acad Sci USA 107:15081-15086
17. Börjesson AE, Windahl SH, Lagerquist MK, Engdahl C, Frenkel B, Movérare-Skrtic S, Sjögren K, Kindblom JM, Stubelius A, Islander U, Antal MC, Krust A, Chambon P, Ohlsson C 2011 Roles of transactivating functions 1 and 2 of estrogen receptor-α in bone. Proc Natl Acad Sci USA 108:6288-6293
18. McEwan IJ 2012 Intrinsic disorder in the androgen receptor: identification, characterisation and drugability. Mol BioSyst 8:82-90
19. Zennaro MC, Lombès M 2004 Mineralocorticoid resistance. Trends Endocrinol Metab 15:264-270
20. Boonyaratanakornkit V, Edwards DP 2004 Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. Essays Biochem 40:105-120
21. Gellersen B, Fernandes MS, Brosens JJ 2009 Non-genomic progesterone actions in female reproduction.HumReprod Update 15:119-138
22. McEwen BS 2010 Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling. Ann NY Acad Sci 1204 Suppl:E38-E59
23. Groeneweg FL, Karst H, de Kloet ER, Joëls M 2011 Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol 209:153-167
24. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
25. Escriva H, Bertrand S, Laudet V 2004 The evolution of the nuclear receptor superfamily. Essays Biochem 40:11-26
26. Weinberger C, Hollenberg SM, Ong ES, Harmon JM, Brower ST, Cidlowski J, Thompson EB, Rosenfeld MG, Evans RM 1985 Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science 228:740-742
27. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J 1986 Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150-1154
28. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P 1986 Human oestrogen receptor cDNA: sequence, expression and homology to v-Erb-A. Nature 320:134-139
29. Conneely OM, Sullivan WP, Toft DO, Birnbaumer M, Cook RG, Maxwell BL, Zarucki-Schulz T, Greene GL, Schrader WT, O'Malley BW 1986 Molecular cloning of the chicken progesterone receptor. Science 233:767-770
30. Jeltsch JM, Krozowski Z, Quirin-Stricker C, Gronemeyer H, Simpson RJ, Garnier JM, Krust A, Jacob F, Chambon P 1986 Cloning of the chicken progesterone receptor. Proc Natl Acad Sci USA 83:5424-5428
31. Chang CS, Kokontis J, Liao ST 1988 Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240:324-326
32. Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM 1988 The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 2:1265-1275
33. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM 1985 Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318:635-641
34. Kornberg RD 2007 The molecular basis of eucaryotic transcription. Cell Death Differ 14:1989-1997
35. Malik S, Roeder RG 2010 The metazoan mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet 11:761-772
36. Roeder RG 2005 Transcriptional regulation and the role of diverse coactivators in animal cells. FEBS Lett 579:909-915
37. McNally JG, MüllerWG, Walker D, Wolford R, HagerGL 2000 The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287:1262-1265
38. Stenoien DL, Patel K, ManciniMG, Dutertre M, Smith CL, O'Malley BW, Mancini MA 2001 FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasomedependent. Nat Cell Biol 3:15-23
39. Nagaich AK, Walker DA, Wolford R, Hager GL 2004 Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol Cell 14: 163-174
40. van Royen ME, Cunha SM, Brink MC, Mattern KA, Nigg AL, Dubbink HJ, Verschure PJ, Trapman J, Houtsmuller AB 2007 Compartmentalization of androgen receptor protein-protein interactions in living cells. J Cell Biol 177: 63-72
41. Rayasam GV, Elbi C, Walker DA, Wolford R, Fletcher TM, Edwards DP, HagerGL 2005 Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol 25:2406-2418
42. Berry M, Metzger D, Chambon P 1990 Role of the two activating domains of the oestrogen receptor in the celltype and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.EMBOJ 9:2811-2818
43. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engström O, Ohman L, Greene GL, Gustafsson JA, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758
44. Xu J, Wu RC, O'Malley BW 2009 Normal and cancerrelated functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9:615-630
45. Bulynko YA, O'Malley BW 2011 Nuclear receptor coactivators: structural and functional biochemistry. Biochemistry 50:313-328
46. Smith CL, O'Malley BW 2004 Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45-71
47. Ball LJ, Levy N, Zhao X, Griffin C, Tagliaferri M, Cohen I, Ricke WA, Speed TP, Firestone GL, Leitman DC 2009 Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements. Mol Cell Endocrinol 299:204-211
48. Spillman MA, Manning NG, Dye WW, Sartorius CA, Post MD, Harrell JC, Jacobsen BM, Horwitz KB 2010 Tissuespecific pathways for estrogen regulation of ovarian cancer growth and metastasis. Cancer Res 70:8927-8936
49. Kumar R, Thompson EB 2003 Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. Mol Endocrinol 17:1-10
50. Lavery DN, McEwan IJ 2005 Structure and function of steroid receptorAF1transactivation domains: induction of active conformations. Biochem J 391:449-464
51. McEwan IJ, Lavery D, Fischer K, Watt K 2007 Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors. Nucl Recept Signal 5:e001
52. Wrange O, Gustafsson JA 1978 Separation of the hormone-and DNA-binding sites of the hepatic glucocorticoid receptor by means of proteolysis. J Biol Chem 253:856-865
53. Carlstedt-Duke J, Okret S, Wrange O, Gustafsson JA 1982 Immunochemical analysis of the glucocorticoid receptor: identification of a third domain separate from the steroidbinding and DNA-binding domains. Proc Natl Acad Sci USA 79:4260-4264
54. Carlstedt-Duke J, Strömstedt PE, Wrange O, Bergman T, Gustafsson JA, Jörnvall H 1987 Domain structure of the glucocorticoid receptor protein. Proc Natl Acad Sci USA 84:4437-4440
55. Smith DF 1993 Dynamics of heat shock protein 90-progesterone receptor binding and the disactivation loop model for steroid receptor complexes. Mol Endocrinol 7:1418-1429
56. Pratt WB, Morishima Y, Osawa Y 2008 The Hsp90 chaperone machinery regulates signaling by modulating ligand binding clefts. J Biol Chem 283:22885-22889
57. Kaul S, Murphy PJ, Chen J, Brown L, Pratt WB, Simons SS. Jr 2002 Mutations at positions 547-553 of rat glucocorticoid receptors reveal that hsp90 binding requires the presence, but not defined composition, of a seven-amino acid sequence at the amino terminus of the ligand binding domain. J Biol Chem 277:36223-36232
58. Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S, Yamamoto KR 1990 Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348: 166-168
59. Freeman BC, Yamamoto KR 2002 Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296:2232-2235
60. Huang P, Chandra V, Rastinejad F 2010 Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol 72:247-272
61. Eick GN, Thornton JW 2011 Evolution of steroid receptors from an estrogen-sensitive ancestral receptor.MolCell Endocrinol 334:31-38
62. Heery DM, Kalkhoven E, Hoare S, Parker MG 1997 A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733-736
63. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR 1998 Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 12:3343-3356
64. Nagy L, Schwabe JW 2004 Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci 29:317-324
65. Dubbink HJ, Hersmus R, Verma CS, van der Korput HA, Berrevoets CA, van Tol J, Ziel-van der Made AC, Brinkmann AO, Pike AC, Trapman J 2004 Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor. Mol Endocrinol 18:2132-2150
66. He B, Gampe Jr RT, Kole AJ, Hnat AT, Stanley TB, An G, Stewart EL, Kalman RI, Minges JT, Wilson EM 2004 Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol Cell 16:425-438
67. Hur E, Pfaff SJ, Payne ES, Grøn H, Buehrer BM, Fletterick RJ 2004 Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol 2:E274
68. Ricketson D, Hostick U, Fang L, Yamamoto KR, Darimont BD 2007 A conformational switch in the ligandbinding domain regulates the dependence of the glucocorticoid receptor on Hsp90. J Mol Biol 368:729-741
69. Egea PF, Klaholz BP, Moras D 2000 Ligand-protein interactions in nuclear receptors of hormones. FEBS Lett 476: 62-67
70. Pike AC, Brzozowski AM, Hubbard RE 2000 A structural biologist's view of the oestrogen receptor. J Steroid Biochem Mol Biol 74:261-268
71. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
72. McInerney EM, Katzenellenbogen BS 1996 Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J Biol Chem 271:24172-24178
73. Mérot Y, Métivier R, Penot G, Manu D, Saligaut C, Gannon F, Pakdel F, Kah O, Flouriot G 2004 The relative contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor α transcriptional activity depends upon the differentiation stage of the cell. J Biol Chem 279:26184-26191
74. Estébanez-Perpiñá E, Arnold LA, Arnold AA, Nguyen P, Rodrigues ED, Mar E, Bateman R, Pallai P, Shokat KM, Baxter JD, Guy RK, Webb P, Fletterick RJ 2007 A surface on the androgen receptor that allosterically regulates coactivator binding. Proc Natl Acad Sci USA 104:16074-16079
75. Fawell SE, Lees JA, White R, Parker MG 1990 Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60:953-962
76. Savory JG, Préfontaine GG, Lamprecht C, Liao M, Walther RF, Lefebvre YA, Haché RJ 2001 Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces. Mol Cell Biol 21:781-793
77. Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKeeDD, ConslerTG, Parks DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE 2002 Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110:93-105
78. Centenera MM, Harris JM, Tilley WD, Butler LM 2008 The contribution of different androgen receptor domains to receptor dimerization and signaling. Mol Endocrinol 22:2373-2382
79. Langley E, Zhou ZX, Wilson EM 1995 Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem 270:29983-29990
80. Langley E, Kemppainen JA, Wilson EM 1998 Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. J Biol Chem 273:92-101
81. Doesburg P, Kuil CW, Berrevoets CA, Steketee K, Faber PW, Mulder E, Brinkmann AO, Trapman J 1997 Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 36:1052-1064
82. He B, Kemppainen JA, Wilson EM 2000 FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 275:22986-22994
83. He B, Lee LW, Minges JT, Wilson EM 2002 Dependence of selective gene activation on the androgen receptor NH2-and COOH-terminal interaction. J Biol Chem 277:25631-25639
84. Callewaert L, Verrijdt G, Christiaens V, Haelens A, Claessens F 2003 Dual function of an amino-terminal amphipatic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements. J Biol Chem 278:8212-8218
85. Métivier R, Penot G, Flouriot G, Pakdel F 2001 Synergism between ERα transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 α-helical core and for a direct interaction between the N- and C-terminal domains. Mol Endocrinol 15:1953-1970
86. Kraus WL, McInerney EM, Katzenellenbogen BS 1995 Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc Natl Acad Sci USA 92: 12314-12318
87. Tetel MJ, Giangrande PH, Leonhardt SA, McDonnell DP, Edwards DP 1999 Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol Endocrinol 13:910-924
88. Dong X, Challis JR, Lye SJ 2004 Intramolecular interactions between the AF3 domain and the C-terminus of the human progesterone receptor are mediated through two LXXLL motifs. J Mol Endocrinol 32:843-857
89. Pippal JB, Yao Y, Rogerson FM, Fuller PJ 2009 Structural and functional characterisation of the interdomain interaction in the mineralocorticoid receptor. Mol Endocrinol 23:1360-1370
90. Claessens F, Gewirth DT 2004 DNA recognition by nuclear receptors. Essays Biochem 40:59-72
91. Härd T, Kellenbach E, Boelens R, Maler BA, Dahlman K, Freedman LP, Carlstedt-Duke J, Yamamoto KR, Gustafsson JA, Kaptein R 1990 Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249: 157-160
92. Schwabe JW, Neuhaus D, Rhodes D 1990 Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 348:458-461
93. Schwabe JW, Chapman L, Finch JT, Rhodes D 1993 The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75:567-578
94. Shaffer PL, Jivan A, Dollins DE, Claessens F, Gewirth DT 2004 Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci USA 101:4758-4763
95. Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR 2009 DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324: 407-410
96. Roemer SC, Donham DC, Sherman L, Pon VH, Edwards DP, Churchill ME 2006 Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. Mol Endocrinol 20:3042-3052
97. Wardell SE, Kwok SC, Sherman L, Hodges RS, Edwards DP 2005 Regulation of the amino-terminal transcription activation domain of progesterone receptor by a cofactorinduced protein folding mechanism. Mol Cell Biol 25: 8792-8808
98. Daniel AR, Gaviglio AL, Czaplicki LM, Hillard CJ, Housa D, Lange CA 2010 The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. Mol Endocrinol 24:2126-2138
99. Cutress ML, Whitaker HC, Mills IG, Stewart M, Neal DE 2008 Structural basis for the nuclear import of the human androgen receptor. J Cell Sci 121:957-968
100. Tanner TM, Denayer S, Geverts B, Van Tilborgh N, Kerkhofs S, Helsen C, Spans L, Dubois V, Houtsmuller AB, Claessens F, Haelens A 2010 A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels. Cell Mol Life Sci 67:1919-1927
101. Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L, Ogryzko V, Avantaggiati ML, Pestell RG 2000 P300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem 275:20853-20860
102. FuM, WangC, WangJ, Zhang X, Sakamaki T, Yeung YG, Chang C, Hopp T, Fuqua SA, Jaffray E, Hay RT, Palvimo JJ, Jänne OA, Pestell RG 2002 Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and transrepression function. Mol Cell Biol 22:3373-3388
103. Faus H, Haendler B 2008 Androgen receptor acetylation sites differentially regulate gene control. J Cell Biochem 104:511-524
104. Gaughan L, Stockley J, Wang N, McCracken SR, Treumann A, Armstrong K, Shaheen F, Watt K, McEwan IJ, Wang C, Pestell RG, Robson CN 2011 Regulation of the androgen receptor by SET9-mediated methylation. Nucleic Acids Res 39:1266-1279
105. Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, Rastinejad F 2008 Structure of the intact PPAR-γ-RXR-nuclear receptor complex on DNA. Nature 456: 350-356
106. Hill KK, Roemer SC, Jones DN, Churchill ME, Edwards DP 2009 A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain. J Biol Chem 284:24415-24424
107. Zilliacus J, Wright AP, Carlstedt-Duke J, Gustafsson JA 1995 Structural determinants of DNA-binding specificity by steroid receptors. Mol Endocrinol 9:389-400
108. Green S, Kumar V, Theulaz I, Wahli W, Chambon P 1988 The N-terminal DNA-binding 'zinc finger' of the oestrogen and glucocorticoid receptors determines target gene specificity. EMBO J 7:3037-3044
109. Green S, Chambon P 1989 Chimeric receptors used to probe the DNA-binding domain of the estrogen and glucocorticoid receptors. Cancer Res 49:2282s-2285s
110. Schoenmakers E, Verrijdt G, Peeters B, Verhoeven G, Rombauts W, Claessens F 2000 Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J Biol Chem 275:12290-12297
111. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M 2005 Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33-43
112. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M 2006 Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297
113. Bolton EC, So AY, Chaivorapol C, Haqq CM, Li H, Yamamoto KR 2007 Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev 21:2005-2017
114. Kininis M, Chen BS, Diehl AG, Isaacs GD, Zhang T, Siepel AC, Clark AG, Kraus WL 2007 Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogenregulated promoters. Mol Cell Biol 27:5090-5104
115. Massie CE, Adryan B, Barbosa-Morais NL, Lynch AG, TranMG, Neal DE, Mills IG 2007Newandrogen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep 8:871-878
116. So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR 2007 Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 3:e94
117. Wang Q, Li W, Liu XS, Carroll JS, Jänne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M 2007 A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 27:380-392
118. So AY, Cooper SB, Feldman BJ, Manuchehri M, Yamamoto KR 2008 Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes. Proc Natl Acad Sci USA 105:5745-5749
119. Acevedo ML, Kraus WL 2004 Transcriptional activation by nuclear receptors. Essays Biochem 40:73-88
120. Rosenfeld MG, Lunyak VV, Glass CK 2006 Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405-1428
121. Metzger D, Ali S, Bornert JM, Chambon P 1995 Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem 270:9535-9542
122. Hollenberg SM, Evans RM 1988 Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55:899-906
123. Dahlman-Wright K, Almlöf T, McEwan IJ, Gustafsson JA, Wright AP 1994 Delineation of a small region within the major transactivation domain of thehumanglucocorticoid receptor that mediates transactivation of gene expression. Proc Natl Acad Sci USA 91:1619-1623
124. Almlöf T, Gustafsson JA, Wright AP 1997 Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol Cell Biol 17:934-945
125. Almlöf T, Wallberg AE, Gustafsson JA, Wright AP 1998 Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor τ 1-core activation domain and target factors. Biochemistry 37:9586-9594
126. Almlöf T, Wright AP, Gustafsson JA 1995 Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor. J Biol Chem 270:17535-17540
127. Iñiguez-Lluhí JA, Lou DY, Yamamoto KR 1997 Three amino acid substitutions selectively disrupt the activation but not the repression function of the glucocorticoid receptor N terminus. J Biol Chem 272:4149-4156
128. Simental JA, SarM, LaneMV, French FS, WilsonEM1991 Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 266:510-518
129. Jenster G, van der Korput HA, Trapman J, BrinkmannAO 1995 Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 270:7341-7346
130. Chamberlain NL, Whitacre DC, Miesfeld RL 1996 Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J Biol Chem 271:26772-26778
131. Betney R, McEwan IJ 2003 Role of conserved hydrophobic amino acids in androgen receptor AF-1 function. J Mol Endocrinol 31:427-439
132. Takimoto GS, TungL, Abdel-Hafiz H, AbelMG, Sartorius CA, Richer JK, Jacobsen BM, Bain DL, Horwitz KB 2003 Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure. J Steroid Biochem Mol Biol 85:209-219
133. Govindan MV, Warriar N 1998 Reconstitution of the Nterminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. J Biol Chem 273:24439-24447
134. Fuse H, Kitagawa H, Kato S 2000 Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Mol Endocrinol 14:889 -899
135. Fischer K, Kelly SM, Watt K, Price NC, McEwan IJ 2010 Conformation of the mineralocorticoid receptor N-terminal domain: evidence for induced and stable structure. Mol Endocrinol 24:1935-1948
136. Rochel N, Ciesielski F, Godet J, Moman E, Roessle M, Peluso-Iltis C, Moulin M, Haertlein M, Callow P, Mély Y, Svergun DI, Moras D 2011 Common architecture of nuclear receptor heterodimers onDNAdirect repeat elements with different spacings. Nat Struct Mol Biol 18:564-570
137. Putcha BD, Fernandez EJ 2009 Direct interdomain interactions can mediate allosterism in the thyroid receptor. J Biol Chem 284:22517-22524
138. Zhang J, Chalmers MJ, Stayrook KR, Burris LL, Wang Y, Busby SA, Pascal BD, Garcia-Ordonez RD, Bruning JB, Istrate MA, Kojetin DJ, Dodge JA, Burris TP, Griffin PR 2011 DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol 18: 556-563
139. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E, Chambon P 1989 The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59:477-487
140. Rogatsky I, Luecke HF, Leitman DC, Yamamoto KR 2002 Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc Natl Acad Sci USA 99:16701-16706
141. Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, Darimont BD, Garabedian MJ, Yamamoto KR 2003 Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad Sci USA 100:13845-13850
142. Wang Z, Frederick J, Garabedian MJ 2002 Deciphering the phosphorylation " code" of the glucocorticoid receptor in vivo. J Biol Chem 277:26573-26580
143. Blind RD, Garabedian MJ 2008 Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J Steroid Biochem Mol Biol 109: 150-157
144. Billon-Galés A, Fontaine C, Filipe C, Douin-Echinard V, Fouque MJ, Flouriot G, Gourdy P, Lenfant F, Laurell H, Krust A, Chambon P, Arnal JF 2009 The transactivating function 1 of estrogen receptor α is dispensable for the vasculoprotective actions of 17β-estradiol. Proc Natl Acad Sci USA 106:2053-2058
145. Dunker AK, Uversky VN 2010 Drugs for 'protein clouds': targeting intrinsically disordered transcription factors. Curr Opin Pharmacol 10:782-788
146. Babu MM, van der Lee R, de Groot NS, Gsponer J 2011 Intrinsically disordered proteins: regulation and disease. Curr Opin Struct Biol 21:432-440
147. Nilsson J, Grahn M, Wright AP 2011 Proteome-wide evidence for enhanced positive Darwinian selection within intrinsically disordered regions in proteins. Genome Biol 12:R65
148. Rajagopalan K, Mooney SM, Parekh N, Getzenberg RH, Kulkarni P 2011 A majority of the cancer/testis antigens are intrinsically disordered proteins. J Cell Biochem 112: 3256-3267
149. Tompa P 2011 Unstructural biology coming of age. Curr Opin Struct Biol 21:419-425
150. Uversky VN 2011 Intrinsically disordered proteins fromA to Z. Int J Biochem Cell Biol 43:1090-1103
151. Demarest SJ, Martinez-Yamout M, Chung J, Chen H, Xu W, Dyson HJ, Evans RM, Wright PE 2002 Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature 415:549-553
152. Vacic V, Oldfield CJ, Mohan A, Radivojac P, Cortese MS, Uversky VN, Dunker AK 2007 Characterization of molecular recognition features, MoRFs, and their binding partners. J Proteome Res 6:2351-2366
153. Dunker AK, Uversky VN 2008 Signal transduction via unstructured protein conduits. Nat Chem Biol 4:229-230
154. Wright PE, Dyson HJ 2009 Linking folding and binding. Curr Opin Struct Biol 19:31-38
155. Verkhivker GM, Bouzida D, Gehlhaar DK, Rejto PA, Freer ST, Rose PW 2003 Simulating disorder-order transitions in molecular recognition of unstructured proteins: where folding meets binding. Proc Natl Acad Sci USA 100:5148-5153
156. Liu J, Perumal NB, Oldfield CJ, Su EW, Uversky VN, Dunker AK 2006 Intrinsic disorder in transcription factors. Biochemistry 45:6873-6888
157. Mao AH, Crick SL, Vitalis A, Chicoine CL, Pappu RV 2010 Net charge per residue modulates conformational ensembles of intrinsically disordered proteins. Proc Natl Acad Sci USA 107:8183-8188
158. Wang X, Zhang S, Zhang J, Huang X, Xu C, Wang W, Liu Z, Wu J, Shi Y 2010 A large intrinsically disordered region in SKIP and its disorder-order transition induced by PPIL1 binding revealed by NMR. J Biol Chem 285:4951-4963
159. Kulkarni P, Rajagopalan K, Yeater D, Getzenberg RH 2011 Protein folding and the order/disorder paradox. J Cell Biochem 112:1949-1952
160. Yoon MK, Shin J, Choi G, Choi BS 2006 Intrinsically unstructured N-terminal domain of bZIP transcription factor HY5. Proteins 65:856-866
161. Kjaergaard M, Teilum K, Poulsen FM 2010 Conformational selection in the molten globule state of the nuclear coactivator binding domain of CBP. Proc Natl Acad Sci USA 107:12535-12540
162. Midic U, Oldfield CJ, Dunker AK, Obradovic Z, Uversky VN 2009 Unfoldomics of human genetic diseases: illustrative examples of ordered and intrinsically disordered members of the human diseasome. Protein Pept Lett 16:1533-1547
163. Joerger AC, Fersht AR 2008 Structural biology of the tumor suppressor p53. Annu Rev Biochem 77:557-582
164. Kumar R, Litwack G 2009 Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain. Steroids 74:877-883
165. Garza AS, Ahmad N, Kumar R 2009 Role of intrinsically disordered protein regions/domains in transcriptional regulation. Life Sci 84:189-193
166. KrasowskiMD, Reschly EJ, Ekins S 2008 Intrinsic disorder in nuclear hormone receptors. J Proteome Res 7:4359-4372
167. Uversky VN, Oldfield CJ, Dunker AK 2008 Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu Rev Biophys 37:215-246
168. Eisenhaber B, Eisenhaber F 2007 Posttranslational modifications and subcellular localization signals: indicators of sequence regions without inherent 3D structure? Curr Protein Pept Sci 8:197-203
169. Kumar R, Thompson EB 1999 The structure of the nuclear hormone receptors. Steroids 64:310-319
170. Kumar R, Johnson BH, Thompson EB 2004 Overview of the structural basis for transcription regulation by nuclear hormone receptors. Essays Biochem 40:27-39
171. McEwan IJ, Nardulli AM 2009 Nuclear hormone receptor architecture-form and dynamics: the 2009 FASEB summer conference on dynamic structure of the nuclear hormone receptors. Nucl Recept Signal 7:e011
172. Dahlman-Wright K, Baumann H, McEwan IJ, Almlöf T, Wright AP, Gustafsson JA, Härd T 1995 Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc Natl Acad Sci USA 92:1699-1703
173. Baskakov IV, Kumar R, Srinivasan G, Ji YS, Bolen DW, Thompson EB 1999 Trimethylamine N-oxide-induced cooperative folding of an intrinsically unfolded transcription-activating fragment of human glucocorticoid receptor. J Biol Chem 274:10693-10696
174. Bain DL, Franden MA, McManaman JL, Takimoto GS, Horwitz KB 2001 The N-terminal region of human progesterone B-receptors: biophysical and biochemical comparison to A-receptors. J Biol Chem 276:23825-23831
175. Wärnmark A, Wikström A, Wright AP, Gustafsson JA, Härd T 2001 The N-terminal regions of estrogen receptor α and β are unstructured in vitro and show different TBP binding properties. J Biol Chem 276:45939-45944
176. Reid J, Kelly SM, Watt K, Price NC, McEwan IJ 2002 Conformational analysis of the androgen receptor aminoterminal domain involved in transactivation. Influence of structure-stabilizing solutes and protein-protein interactions. J Biol Chem 277:20079-20086
177. Shen HC, Buchanan G, Butler LM, Prescott J, Henderson M, Tilley WD, Coetzee GA 2005 GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor. Biol Chem 386:69-74
178. Georgiakaki M, Chabbert-Buffet N, Dasen B, Meduri G, Wenk S, Rajhi L, Amazit L, Chauchereau A, Burger CW, Blok LJ, Milgrom E, Lombès M, Guiochon-Mantel A, Loosfelt H 2006 Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the Nterminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription. Mol Endocrinol 20:2122-2140
179. Lavery DN, McEwan IJ 2008 Functional characterization of the native NH2-terminal transactivation domain of the human androgen receptor: binding kinetics for interactions with TFIIF and SRC-1a. Biochemistry 47:3352-3359
180. Garza AM, Khan SH, Kumar R 2010 Site-specific phosphorylation induces functionally active conformation in the intrinsically disordered N-terminal activation function (AF1) domain of the glucocorticoid receptor. Mol Cell Biol 30:220-230
181. Wardell SE, Narayanan R, Weigel NL, Edwards DP 2010 Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine 400. Mol Endocrinol 24:335-345
182. Khan SH, Ling J, Kumar R 2011 TBP binding-induced folding of the glucocorticoid receptor AF1 domain facilitates its interaction with steroid receptor coactivator-1. PLoS One 6:e21939
183. Kumar R, Baskakov IV, Srinivasan G, Bolen DW, Lee JC, Thompson EB 1999 Interdomain signaling in a two-domain fragment of thehumanglucocorticoid receptor. J Biol Chem 274:24737-24741
184. Brodie J, McEwan IJ 2005 Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding. J Mol Endocrinol 34:603-615
185. Cutress RI, Townsend PA, Sharp A, Maison A, Wood L, Lee R, Brimmell M, Mullee MA, Johnson PW, Royle GT, Bateman AC, Packham G 2003 The nuclear BAG-1 iso-form, BAG-1L, enhances oestrogen-dependent transcription. Oncogene 22:4973-4982
186. Shatkina L, Mink S, Rogatsch H, Klocker H, Langer G, Nestl A, Cato AC 2003 The cochaperone Bag-1L enhances androgen receptor action via interaction with the NH2-terminal region of the receptor. Mol Cell Biol 23:7189-7197
187. Kumar R, Lee JC, Bolen DW, Thompson EB 2001 The conformation of the glucocorticoid receptor af1/tau1 domain induced by osmolyte binds co-regulatory proteins. J Biol Chem 276:18146-18152
188. Kumar R, Betney R, Li J, Thompson EB, McEwan IJ 2004 Induced α-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF. Biochemistry 43: 3008-3013
189. Lavery DN, McEwan IJ 2008 Structural characterization of the native NH2-terminal transactivation domain of the human androgen receptor: a collapsed disordered conformation underlies structural plasticity and protein-induced folding. Biochemistry 47:3360-3369
190. Khan SH, Arnott JA, Kumar R 2011 Naturally occurring osmolyte, trehalose induces functional conformation in an intrinsically disordered activation domain of glucocorticoid receptor. PLoS One 6:e19689
191. Dahlman-Wright K, McEwan IJ 1996 Structural studies of mutant glucocorticoid receptor transactivation domains establish a link between transactivation activity in vivo and α-helix-forming potential in vitro. Biochemistry 35:1323-1327
192. Timasheff SN 2002 Protein-solvent preferential interactions, protein hydration, and the modulation of biochemical reactions by solvent components. Proc Natl Acad Sci USA 99:9721-9726
193. Street TO, Bolen DW, Rose GD 2006 A molecular mechanism for osmolyte-induced protein stability. Proc Natl Acad Sci USA 103:13997-14002
194. Kumar R 2009 Role of naturally occurring osmolytes in protein folding and stability. Arch Biochem Biophys 491: 1-6
195. Holthauzen LM, Rösgen J, Bolen DW 2010 Hydrogen bonding progressively strengthens upon transfer of the protein urea-denatured state to water and protecting osmolytes. Biochemistry 49:1310-1318
196. Kumar R, Serrette JM, Khan SH, Miller AL, ThompsonEB 2007 Effects of different osmolytes on the induced folding of the N-terminal activation domain (AF1) of the glucocorticoid receptor. Arch Biochem Biophys 465:452-460
197. Kumar R 2008 Osmolyte-induced folding of an intrinsically disordered activation function subdomain of glucocorticoid receptor. J Recept Signal Transduct Res 28:465-474
198. Fu M, Rao M, Wu K, Wang C, Zhang X, Hessien M, Yeung YG, Gioeli D, Weber MJ, Pestell RG 2004 The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. J Biol Chem 279:29436-29449
199. Loven MA, Likhite VS, Choi I, Nardulli AM 2001 Estrogen response elements alter coactivator recruitment through allosteric modulation of estrogen receptor β conformation. J Biol Chem 276:45282-45288
200. Wood JR, Greene GL, Nardulli AM 1998 Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol Cell Biol 18:1927-1934
201. Wood JR, Likhite VS, Loven MA, Nardulli AM 2001 Allosteric modulation of estrogen receptor conformation by different estrogen response elements. Mol Endocrinol 15: 1114-1126
202. Barkhem T, Haldosén LA, Gustafsson JA, Nilsson S 2002 PS2 Gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor α, an estrogen-responsive element, and the activator protein 1 response element. Mol Pharmacol 61:1273-1283
203. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
204. Glass CK, Rose DW, Rosenfeld MG 1997 Nuclear receptor coactivators. Curr Opin Cell Biol 9:222-232
205. McEwan IJ, Dahlman-Wright K, Ford J, Wright AP 1996 Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding. Biochemistry 35:9584-9593
206. Dyson HJ, Wright PE 2002 Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol 12: 54-60
207. Dunker AK, Silman I, Uversky VN, Sussman JL 2008 Function and structure of inherently disordered proteins. Curr Opin Struct Biol 18:756-764
208. Iakoucheva LM, Brown CJ, Lawson JD, Obradoviæ Z, Dunker AK 2002 Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol 323:573-584
209. Iakoucheva LM, Radivojac P, Brown CJ, O'Connor TR, Sikes JG, Obradovic Z, Dunker AK 2004 The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res 32:1037-1049
210. Bevan CL, Hoare S, Claessens F, Heery DM, Parker MG 1999 The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol 19: 8383-8392
211. Benecke A, Chambon P, Gronemeyer H 2000 Synergy between estrogen receptor α activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2. EMBO Rep 1:151-157
212. Onate SA, Boonyaratanakornkit V, Spencer TE, Tsai SY, Tsai MJ, Edwards DP, O'Malley BW 1998 The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem 273:12101-12108
213. Powell SM, Christiaens V, Voulgaraki D, Waxman J, Claessens F, Bevan CL 2004 Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate. Endocr Relat Cancer 11:117-130
214. Sugase K, Dyson HJ, Wright PE 2007 Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature 447:1021-1025
215. Reid J, Murray I, Watt K, Betney R, McEwan IJ 2002 The androgen receptor interacts with multiple regions of the large subunit of general transcription factor TFIIF. J Biol Chem 277:41247-41253
216. Shoemaker BA, Portman JJ, Wolynes PG 2000 Speeding molecular recognition by using the folding funnel: the flycasting mechanism. Proc Natl Acad Sci USA 97:8868-8873
217. Hermann S, Berndt KD, Wright AP 2001 How transcriptional activators bind target proteins. J Biol Chem 276: 40127-40132
218. Ferreira ME, Hermann S, Prochasson P, Workman JL, Berndt KD, Wright AP 2005 Mechanism of transcription factor recruitment by acidic activators. J Biol Chem 280: 21779-21784
219. Wardell SE, Boonyaratanakornkit V, Adelman JS, Aronheim A, Edwards DP 2002 Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. Mol Cell Biol 22:5451-5466
220. Zor T, Mayr BM, Dyson HJ, Montminy MR, Wright PE 2002 Roles of phosphorylation and helix propensity in the binding of the KIX domain of CREB-binding protein by constitutive (c-Myb) and inducible (CREB) activators. J Biol Chem 277:42241-42248
221. Duma D, Jewell CM, Cidlowski JA 2006 Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol 102: 11-21
222. Wang C, Tian L, Popov VM, Pestell RG 2011 Acetylation and nuclear receptor action. J Steroid Biochem Mol Biol 123:91-100
223. Ko S, Ahn J, Song CS, Kim S, Knapczyk-Stwora K, Chatterjee B 2011 Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase. Mol Endocrinol 25:433-444
224. TremblayAM, Wilson BJ, Yang XJ, Giguère V 2008 Phosphorylation-dependent sumoylation regulates estrogen-related receptor-α and -γ transcriptional activity through a synergy control motif. Mol Endocrinol 22:570-584
225. Weigel NL, Moore NL 2007 Steroid receptor phosphorylation: a key modulator of multiple receptor functions.Mol Endocrinol 21:2311-2319
226. Chen D, Riedl T, Washbrook E, Pace PE, Coombes RC, Egly JM, Ali S 2000 Activation of estrogen receptor α by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell 6:127-137
227. Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, Thompson EB 2005 P38 Mitogen-activated protein kinase(MAPK)is a key mediator in glucocorticoidinduced apoptosis of lymphoid cells: correlation between p38MAPKactivation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 19:1569-1583
228. Chen W, Dang T, Blind RD, Wang Z, Cavasotto CN, Hittelman AB, Rogatsky I, Logan SK, Garabedian MJ 2008 Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol 22:1754-1766
229. Chen YX, Du JT, Zhou LX, Liu XH, Zhao YF, Nakanishi H, Li YM 2006 Alternative O-GlcN acylation/O-phosphorylation of Ser16 induce different conformational disturbances to theNterminus of murine estrogen receptorβ. Chem Biol 13:937-944
230. Lefstin JA, Yamamoto KR 1998 Allosteric effects of DNA on transcriptional regulators. Nature 392:885-888
231. Nettles KW, Sun J, Radek JT, Sheng S, Rodriguez AL, Katzenellenbogen JA, Katzenellenbogen BS, Greene GL 2004 Allosteric control of ligand selectivity between estrogen receptors α and β: implications for other nuclear receptors. Mol Cell 13:317-327
232. Hilser VJ, Thompson EB 2007 Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins. Proc Natl Acad Sci USA 104:8311-8315
233. Kumar R, Thompson EB 2010 Influence of flanking sequences on signaling between the activation function AF1 and DNA-binding domain of the glucocorticoid receptor. Arch Biochem Biophys 496:140-145
234. McDonnell DP 2000 Selective estrogen receptor modulators (SERMs): a first step in the development of perfect hormone replacement therapy regimen. J Soc Gynecol Investig 7:S10-S15
235. McDonnell DP, Chang CY, Norris JD 2000 Development of peptide antagonists that target estrogen receptor-cofactor interactions. J Steroid Biochem Mol Biol 74:327-335
236. Paige LA, Christensen DJ, Grøn H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM 1999 Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β. Proc Natl Acad Sci USA 96:3999 -4004
237. Wijayaratne AL, Nagel SC, Paige LA, Christensen DJ, Norris JD, Fowlkes DM, McDonnell DP 1999 Comparative analyses of mechanistic differences among antiestrogens. Endocrinology 140:5828-5840
238. Yang J, Chang CY, Safi R, Morgan J, McDonnell DP, Fuller PJ, Clyne CD, Young MJ 2011 Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display. Mol Endocrinol 25: 32-43
239. Mao C, PattersonNM, Cherian MT, Aninye IO, Zhang C, Montoya JB, Cheng J, Putt KS, Hergenrother PJ, Wilson EM, Nardulli AM, Nordeen SK, Shapiro DJ 2008 A new small molecule inhibitor of estrogen receptor α binding to estrogen response elements blocks estrogen-dependent growth of cancer cells. J Biol Chem 283:12819-12830
240. Jones JO, Bolton EC, Huang Y, Feau C, Guy RK, Yamamoto KR, Hann B, Diamond MI 2009 Non-competitive androgen receptor inhibition in vitro and in vivo. Proc Natl Acad Sci USA 106:7233-7238
241. Andersen RJ, MawjiNR, WangJ, WangG, Haile S, Myung JK, Watt K, Tam T, Yang YC, Bañuelos CA, Williams DE, McEwan IJ, Wang Y, Sadar MD 2010 Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell 17:535-546
242. Davies P, Watt K, Kelly SM, Clark C, Price NC, McEwan IJ 2008 Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain. J Mol Endocrinol 41:301-314
243. Kumar R, Volk DE, Li J, Lee JC, Gorenstein DG, Thompson EB 2004 TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain. Proc Natl Acad Sci USA 101:16425-16430
244. Nocula-£ugowska M, Rymarczyk G, Lisowski M, Ozyhar A 2009 Isoform-specific variation in the intrinsic disorder of the ecdysteroid receptor N-terminal domain. Proteins 76:291-308
245. Dziedzic-Letka A, Rymarczyk G, Kapłon TM, Górecki A, Szamborska-Gbur A, Wojtas M, Dobryszycki P, O¿yharA 2011 Intrinsic disorder of Drosophila melanogaster hormone receptor 38 N-terminal domain. Proteins 79:376-392
246. He B, Bai S, Hnat AT, Kalman RI, Minges JT, Patterson C, Wilson EM 2004 An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP). J Biol Chem 279: 30643-30653
247. Oldfield CJ, Cheng Y, Cortese MS, Brown CJ, Uversky VN, Dunker AK 2005 Comparing and combining predictors of mostly disordered proteins. Biochemistry 44:1989-2000
248. Yang ZR, Thomson R, McNeil P, Esnouf RM 2005 RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 21:3369-3376
249. Linding R, Russell RB, Neduva V, Gibson TJ 2003 Glob-Plot: exploring protein sequences for globularity and disorder. Nucleic Acids Res 31:3701-3708
250. Prilusky J, Felder CE, Zeev-Ben-Mordehai T, RydbergEH, Man O, Beckmann JS, Silman I, Sussman JL 2005 Fold-Index: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 21: 3435-3438